Abstract
Objective Currently, in Portugal, there is a lack of validated scales to measure depression stigma; therefore, validation of the Depression Stigma Scale (DSS) is an essential step to the depression stigma research in Portugal.
Methods The adaptation process was developed with the ITC Guidelines for Translation and Adapting Tests taken in consideration.
The sample was collected as part of the OSPI program – Optimizing suicide prevention programs and their implementation in Europe, specifically within the application in Portugal, and 1693 participants were included. Floor-ceiling effects and response ranges were analyzed, and we calculated Cronbach alphas, conducted a Principal Component Analysis, and Confirmatory Analysis. Validity evidence was tested with two well documented hypotheses, using data on gender and depression symptoms.
Results The sample was well comparable with the Portuguese general population, indicating its representativeness. A three-factor structure was identified in each subscale (personal and perceived stigma): weak-not-sick, discrimination, and, dangerous/unpredictable. The Cronbach’s alphas were satisfactory, and validity was confirmed.
Conclusions The scale showed good psychometric properties in the Portuguese population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this study was provided by the European Community Seventh Framework Program (FP7/2007 2013) under grant agreement no. 223138. The funding agency had no role in the design of the study, nor in the data collection, nor the analyses and interpretation of the data, nor in the writing of the manuscript, nor in the decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The approval of the study protocol occurred in the scope of the OSPI program. In Portugal, the OSPI study was approved by the Medical Sciences Faculty of the New University of Lisbon ethics commission in May 2009.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data avalabe upon request to the corresponding author